Detailed price information for Transmedics Group Inc (TMDX-Q) from The Globe and Mail including charting and trades.
Tampa General Hospital has performed more than 15,000 organ transplants since its program launched in 1974 — a milestone ...
TransMedics' Q1 revenues rise 21% on strong OCS demand, but a sharp EPS miss and margin pressure send shares down despite ...
TransMedics Group faces renewed market focus as earnings trends, analyst sentiment, and healthcare innovation reshape Nasdaq ...
Thank you so much, Hannah. As always, joining me today is Gerardo Hernandez, our Chief Financial Officer. Since inception, TransMedics has been relentless in our pursuit to transform organ transplant ...
Q1 began reporting non-GAAP “adjusted” metrics and framed 2026 as an "accelerated phase of investment," while Q4 emphasized 2025 profitability milestones and included a large one-time tax benefit in ...
The Montreal Heart Institute and CHU Sainte-Justine are set to begin using a cutting-edge device that will expand access to cardiac transplantation MONTREAL, April 30, 2026 /CNW/ ...
United States-based medical technology company TransMedics has entered into a definitive agreement to invest in Germany-based private aviation operator PAD Aviation (PVD, Paderbor ...
Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate TransMedics Group, Inc. before investing. In this article, we go over a few key ...
TransMedics is helping improve organ transplantation thanks to its innovative organ storage system. The company has posted strong financial results over the past few years, and the stock is soaring.
Innovations often (but not always) drive life-changing returns for the companies that engineer them and the people who get in on the ground floor. That's why investors should sometimes look toward ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results